Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pavan Bhargava

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Accelerated Metabolomic Aging and Its Association with Social Determinants of Health in Multiple SclerosisFatemeh Siavoshi, Rezvan Noroozi, Gina Chang, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 17, 2023
A Phase 1b, Open-Label Study to Evaluate the Safety and Tolerability of the Putative Remyelinating Agent, Liothyronine, in Individuals with MSScott D Newsome, Fan Tian, Thomas Shoemaker, et al.
Ebiomedicine|July 11, 2022
Intermittent calorie restriction alters T cell subsets and metabolic markers in people with multiple sclerosisKathryn C Fitzgerald, Pavan Bhargava, Matthew D Smith, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 20, 2023
Serum macrophage migration inhibitory factor levels predict brain atrophy in people with primary progressive multiple sclerosisDimitrios C Ladakis, Maria I Reyes-Mantilla, Sachin P Gadani, et al.
Current Eye Research|December 15, 2017
Analysis of Agreement of Retinal-Layer Thickness Measures Derived from the Segmentation of Horizontal and Vertical Spectralis OCT Macular ScansNatalia Gonzalez Caldito, Bhavna Antony, Yufan He, et al.
Med (New York, N.Y.)|October 24, 2024
Bile acid metabolites predict multiple sclerosis progression and supplementation is safe in progressive diseaseDimitrios C Ladakis, Kimystian L Harrison, Matthew D Smith, et al.
Medrxiv : the Preprint Server for Health Sciences|January 31, 2024
Bile acid metabolites predict multiple sclerosis progression and supplementation is safe in progressive diseaseDimitrios C Ladakis, Kimystian L Harrison, Matthew D Smith, et al.
Frontiers in Molecular Neuroscience|May 23, 2022
Reactive Astrocytes Derived From Human Induced Pluripotent Stem Cells Suppress Oligodendrocyte Precursor Cell DifferentiationMatthew D Smith, Xitiz Chamling, Alexander J Gill, et al.
Cell Reports. Medicine|November 10, 2021
Multi-omic evaluation of metabolic alterations in multiple sclerosis identifies shifts in aromatic amino acid metabolismKathryn C Fitzgerald, Matthew D Smith, Sol Kim, et al.
Annals of Neurology|July 21, 2015
Optical coherence tomography reflects brain atrophy in multiple sclerosis: A four-year studyShiv Saidha, Omar Al-Louzi, John N Ratchford, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Accelerated Metabolomic Aging and Its Association with Social Determinants of Health in Multiple SclerosisFatemeh Siavoshi, Rezvan Noroozi, Gina Chang, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 17, 2023
A Phase 1b, Open-Label Study to Evaluate the Safety and Tolerability of the Putative Remyelinating Agent, Liothyronine, in Individuals with MSScott D Newsome, Fan Tian, Thomas Shoemaker, et al.
Ebiomedicine|July 11, 2022
Intermittent calorie restriction alters T cell subsets and metabolic markers in people with multiple sclerosisKathryn C Fitzgerald, Pavan Bhargava, Matthew D Smith, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 20, 2023
Serum macrophage migration inhibitory factor levels predict brain atrophy in people with primary progressive multiple sclerosisDimitrios C Ladakis, Maria I Reyes-Mantilla, Sachin P Gadani, et al.
Current Eye Research|December 15, 2017
Analysis of Agreement of Retinal-Layer Thickness Measures Derived from the Segmentation of Horizontal and Vertical Spectralis OCT Macular ScansNatalia Gonzalez Caldito, Bhavna Antony, Yufan He, et al.
Med (New York, N.Y.)|October 24, 2024
Bile acid metabolites predict multiple sclerosis progression and supplementation is safe in progressive diseaseDimitrios C Ladakis, Kimystian L Harrison, Matthew D Smith, et al.
Medrxiv : the Preprint Server for Health Sciences|January 31, 2024
Bile acid metabolites predict multiple sclerosis progression and supplementation is safe in progressive diseaseDimitrios C Ladakis, Kimystian L Harrison, Matthew D Smith, et al.
Frontiers in Molecular Neuroscience|May 23, 2022
Reactive Astrocytes Derived From Human Induced Pluripotent Stem Cells Suppress Oligodendrocyte Precursor Cell DifferentiationMatthew D Smith, Xitiz Chamling, Alexander J Gill, et al.
Cell Reports. Medicine|November 10, 2021
Multi-omic evaluation of metabolic alterations in multiple sclerosis identifies shifts in aromatic amino acid metabolismKathryn C Fitzgerald, Matthew D Smith, Sol Kim, et al.
Annals of Neurology|July 21, 2015
Optical coherence tomography reflects brain atrophy in multiple sclerosis: A four-year studyShiv Saidha, Omar Al-Louzi, John N Ratchford, et al.
Pageof 10